Welcome to Edward Leithe's project group
Our research group studies the role of ubiquitin and ubiquitin-like proteins in cell signaling and cancer. Modification of proteins with ubiquitin and ubiquitin-like proteins controls cellular processes relevant to cancer, such as gene transcription, DNA repair, cell-cycle progression, apoptosis and receptor downregulation. Our research is focused on understanding the role of ubiquitination in the control of intercellular communication via gap junctions, and whether deregulation of the ubiquitin system contributes to loss of this type of cell-cell communication during cancer development. The group is member of "CoE - Centre for Cancer Biomedicine".

| RESEARCH THEMES |
Regulation of intercellular communication via gap junctions
HECT E3 ubiquitin ligases in colorectal cancer development
Group contact information:
Department of Cancer Prevention, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1737
eleithe@rr-research.no
May 7, 2012
Latest publications
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
Dis Colon Rectum, 55 (3), 307-15
PubMed 22469798
The Gap Junction Channel Protein Connexin 43 Is Covalently Modified and Regulated by SUMOylation
J Biol Chem, 287 (19), 15851-61
PubMed 22411987
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
J Transl Med, 10, 36
PubMed 22390413
More publications





Print this page
